Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses

Microcirculation

Volumn 10, Issue 3-4, 2003, Pages 359-370

  Salcedo, Rosalba ^a   Oppenheim, Joost J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenic factors; Chemokine receptors; Chemokines; Endothelial cells; Stromal cell derived factor 1 CXCL12

Indexed keywords

ALPHA CHEMOKINE; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CX3C CHEMOKINE; CYTOKINE; EOTAXIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOPROTEIN; REGULATOR PROTEIN; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; BONE MARROW METASTASIS; BREAST CARCINOMA; CANCER CELL; CARCINOGENESIS; CELL FUNCTION; ENDOTHELIUM CELL; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA; MICROENVIRONMENT; MICROVASCULARIZATION; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SKIN LYMPHOMA; TUMOR CELL; TUMOR GROWTH; VASCULAR ENDOTHELIUM; ANIMAL; CYTOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CHEMOKINES; CHEMOKINES, CXC; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CXCR4;

EID: 0142172456     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7800200     Document Type: Review

References (88)

1. Addison CL, Arenberg DA, Morris SB, Xue YY, Burdick MD, Mulligan MS, Iannettoni MD, Strieter RM. (2000). The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum Gene Ther 11:247-261.
2. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. (1997). The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185:111-120.
3. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM. (1996). Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 97:2792-2802.
4. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM. (1996). Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 184:981-992.
5. Auerbach W, Auerbach R. (1994). Angiogenesis inhibition: a review. Pharmacol Ther 63:265-311.
6. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. (1997). A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644.
7. Begum NA, Coker A, Shibuta K, Swanson RS, Chen LB, Mori M, Barnard GF. (1996). Loss of hIRH mRNA expression from premalignant adenomas and malignant cell lines. Biochem Biophys Res Commun 229:864-868.
8. Berger O, Gan X, Gujuluva C, Burns AR, Sulur G, Stins M, Way D, Witte M, Weinand M, Said J, Kim KS, Taub D, Graves MC, Fiala M. (1999). CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med 5:795-805.
9. Bernardini G, Spinetti G, Ribatti D, Camarda G, Morbidelli L, Ziche M, Santoni A, Capogrossi MC, Napolitano M. (2000). I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood 96:4039-4045.
10. Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Burlini A, Monestiroli S, Gobbi A, Pruneri G, Martinelli G. (2002). CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res 62:3106-3112.
11. Bielenberg DR, Bucana CD, Sanchez R, Donawho CK, Kripke ML, Fidler IJ. (1998). Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 111:864-872.
12. Bielenberg DR, Bucana CD, Sanchez R, Mulliken JB, Folkman J, Fidler IJ. (1999). Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 14:401-408.
13. Bowersox JC, Sorgente N. (1982). Chemotaxis of aortic endothelial cells in response to fibronectin. Cancer Res 42:2547-2551.
14. Cao Y, Chen C, Weatherbee JA, Tsang M, Folkman J. (1995). gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 182:2069-2077.
15. Connolly DT, Stoddard BL, Harakas NK, Feder J. (1987). Human fibroblast-derived growth factor is a mitogen and chemoattractant for endothelial cells. Biochem Biophys Res Commun 144:705-712.
16. Dinney CP, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ. (1998). Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. Cancer Res 58:808-814.
17. Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, Bucana CD, Balbay MD, Bielenberg D, Fidler IJ. (1999). Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 59: 872-879.
18. Ellis LM, Fidler IJ. (1996). Angiogenesis and metastasis. Eur J Cancer 32A:2451-2460.
19. Engelhardt E, Toksoy A, Goebeler M, Debus S, Brocker EB, Gillitzer R. (1998). Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 153:1849-1860.
20. Ezekowitz RA, Mulliken JB, Folkman J. (1992). Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456-1463.
21. Feil C, Augustin HG. (1998). Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun 247:38-45.
22. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. (1991). The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211-218.
23. Fidler IJ, Kumar R, Bielenberg DR, Ellis LM. (1998). Molecular determinants of angiogenesis in cancer metastasis. Cancer J Sci Am 4:S58-S66.
24. Folkman J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
25. Folkman J. (1996). Fighting cancer by attacking its blood supply. Sci Am 275:150-154.
26. Folkman J, Hanahan D. (1991). Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 22:339-347.
27. Folkman J, Watson K, Ingber D, Hanahan D. (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61.
28. Fox JA, Ung K, Tanlimco SG, Jirik FR. (2002). Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1. J Immunol 169:49-54.
29. Friesel RE, Maciag T. (1995). Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 9:919-925.
30. Glaser BM, D'Amore PA, Lutty GA, Fenselau AH, Michels RG, Patz A. (1980). Chemical mediators of intraocular neovascularization. Trans Ophthalmol Soc UK 100:369-373.
31. Glaser BM, D'Amore PA, Seppa H, Seppa S, Schiffmann E. (1980). Adult tissues contain chemoattractants for vascular endothelial cells. Nature 288: 483-484.
32. Goldberg SH, van der Meer P, Hesselgesser J, Jaffer S, Kolson DL, Albright AV, Gonzalez-Scarano F, Lavi E. (2001). CXCR3 expression in human central nervous system diseases. Neuropathol Appl Neurobiol 27:127-138.
33. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM. (1998). Chemokine receptors in human endothelial cells: functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 273:4282-4287.
34. Hanahan D, Folkman J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
35. Imai K, Kobayashi M, Wang J, Shinobu N, Yoshida H, Hamada J, Shindo M, Higashino F, Tanaka J, Asaka M, Hosokawa M. (1999). Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow. Br J Haematol 106:905-911.
36. Jenh CH, Cox MA, Hipkin W, Lu T, Pugliese-Sivo C, Gonsiorek W, Chou CC, Narula SK, Zavodny PJ. (2001). Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor. Cytokine 15:113-121.
37. Joseph-Silverstein J, Rifkin DB. (1987). Endothelial cell growth factors and the vessel wall. Semin Thromb Hemost 13:504-513.
38. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. (1991). Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66: 1095-1104.
39. Kijowski J, Baj-Krzyworzeka M, Majka M, Reca R, Marquez LA, Christofidou-Solomidou M, Janowska-Wieczorek A, Ratajczak MZ. (2001). The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells 19:453-466.
40. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801.
41. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura M. (2000). Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6:3530-3535.
42. Kurokawa T, Sasada R, Iwane M, Igarashi K. (1987). Cloning and expression of cDNA encoding human basic fibroblast growth factor. FEBS Lett 213:189-194.
43. Lavi E, Kolson DL, Ulrich AM, Fu L, Gonzalez-Scarano F. (1998). Chemokine receptors in the human brain and their relationship to HIV infection. J Neurovirol 4:301-311.
44. Luster AD, Greenberg SM, Leder P. (1995). The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 182:219-231.
45. Maciag T, Friesel RE. (1995). Molecular mechanisms of fibroblast growth factor-1 traffick, signaling and release. Thromb Haemost 74:411-414.
46. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
47. Mirshahi F, Pourtau J, Li H, Muraine M, Trochon V, Legrand E, Vannier J, Soria J, Vasse M, Soria C. (2000). SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb Res 99:587-594.
48. Mitra P, Shibuta K, Mathai J, Shimoda K, Banner BF, Mori M, Barnard GF. (1999). CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver. Int J Oncol 14:917-925.
49. Molino M, Woolkalis MJ, Prevost N, Pratico D, Barnathan ES, Taraboletti G, Haggarty BS, Hesselgesser J, Horuk R, Hoxie JA, Brass LF. (2000). CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2. Biochim Biophys Acta 1500:227-240.
50. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
51. Murdoch C, Monk PN, Finn A. (1999). CXC chemokine receptor expression on human endothelial cells. Cytokine 11:704-712.
52. Nagasawa T, Kikutani H, Kishimoto T. (1994). Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA. 91:2305-2309.
53. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B. (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835.
54. Pablos JL, Amara A, Bouloc A, Santiago B, Caruz A, Galindo M, Delaunay T, Virelizier JL, Arenzana-Seisdedos F. (1999). Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol 155:1577-1586.
55. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T. (2002). G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687-694.
56. Regulier E, Paul S, Marigliano M, Kintz J, Poitevin Y, Ledoux C, Roecklin D, Cauet G, Calenda V, Homann HE. (2001). Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach. Cancer Gene Ther 8:45-54.
57. Rempel SA, Dudas S, Ge S, Gutierrez JA. (2000). Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6:102-111.
58. Risau W, Flamme I. (1995). Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91.
59. Rollins BJ. (1997). Chemokines. Blood 90:909-928.
60. Romagnani P, Annunziato F, Lasagni L, Lazzeri E, Beltrame C, Francalanci M, Uguccioni M, Galli G, Cosmi L, Maurenzig L, Baggiolini M, Maggi E, Romagnani S, Serio M. (2001). Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 107: 53-63.
61. Ruth JH, Volin MV, Haines GK 3rd, Woodruff DC, Katschke KJ Jr, Woods JM, Park CC, Morel JC, Koch AE. (2001). Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 44:1568-1581.
62. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ. (2000). Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96:34-40.
63. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ. (2000). Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 14:2055-2064.
64. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ. (1999). Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154:1125-1135.
65. Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, Oppenheim JJ. (2001). Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol 166: 7571-7578.
66. Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G. (2002). Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99:2703-2711.
67. Schrader AJ, Lechner O, Templin M, Dittmar KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J. (2002). CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86:1250-1256.
68. Sehgal A, Keener C, Boynton AL, Warrick J, Murphy GP. (1998). CXCR-4, a chemokine receptor, is over-expressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol 69:99-104.
69. Sehgal A, Ricks S, Boynton AL, Warrick J, Murphy GP. (1998). Molecular characterization of CXCR-4: a potential brain tumor-associated gene. J Surg Oncol 69:239-248.
70. Seppa ST, Seppa HE, Liotta LA, Glaser BM, Martin GR, Schiffmann E. (1983). Cultured tumor cells produce chemotactic factors specific for endothelial cells: a possible mechanism for tumor-induced angiogenesis. Invasion Metastasis 3:139-150.
71. Sgadari C, Angiolillo AL, Cherney BW, Pike SE, Farber JM, Koniaris LG, Vanguri P, Burd PR, Sheikh N, Gupta G, Teruya-Feldstein J, Tosato G. (1996). Interferon-inducible protein- 10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci USA. 93:13791-13796.
72. Sgadari C, Farber JM, Angiolillo AL, Liao F, Teruya-Feldstein J, Burd PR, Yao L, Gupta G, Kanegane C, Tosato G. (1997). Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood 89:2635-2643.
73. Shibuta K, Begum NA, Mori M, Shimoda K, Akiyoshi T, Barnard GF. (1997). Reduced expression of the CXC chemokine hIRH/SDF-1alpha mRNA in hepatoma and digestive tract cancer. Int J Cancer 73:656-662.
74. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honjo T. (1995). Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28:495-500.
75. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM. (1994). Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179: 1409-1415.
76. Soto H, Wang W, Strieter RM, Copeland NG, Gilbert DJ, Jenkins NA, Hedrick J, Zlotnik A. (1998). The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc Natl Acad Sci USA. 95:8205-8210.
77. Spinetti G, Camarda G, Bernardini G, Romano Di Peppe S, Capogrossi MC, Napolitano M. (2001). The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells. Biochem Biophys Res Commun 289: 19-24.
78. Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL. (1995). The role of CXC chemokines as regulators of angiogenesis. Shock 4:155-160.
79. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, et al. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348-27357.
80. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T. (1998). The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591-594.
81. Terranova VP, DiFlorio R, Lyall RM, Hic S, Friesel R, Maciag T. (1985). Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol 101:2330-2334.
82. Van Der Meer P, Goldberg SH, Fung KM, Sharer LR, Gonzalez-Scarano F, Lavi E. (2001). Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain. J Neuropathol Exp Neurol 60:25-32.
83. Volin MV, Joseph L, Shockley MS, Davies PF. (1998). Chemokine receptor CXCR4 expression in endothelium. Biochem Biophys Res Commun 242:46-53.
84. Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE. (2001). Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 159:1521-1530.
85. Wang W, Wang X, Ward AC, Touw IP, Friedman AD. (2001). C/EBPalpha and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes. Leukemia 15:779-786.
86. Weber KS, Nelson PJ, Grone HJ, Weber C. (1999). Expression or CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 19:2085-2093.
87. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M. (1997). Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17: 4015-4023.
88. Zetter BR. (1980). Migration of capillary endothelial cells is stimulated by tumor-derived factors. Nature 285:41-43.